China Biotech Services Holdings Limited (8037.HK)

HKD 0.49

(6.52%)

Long Term Debt Summary of China Biotech Services Holdings Limited

China Biotech Services Holdings Limited's latest annual long term debt in 2023 was 5.72 Million HKD , down -91.21% from previous year.
China Biotech Services Holdings Limited's latest quarterly long term debt in 2024 Q1 was - HKD , down 0.0% from previous quarter.
China Biotech Services Holdings Limited reported annual long term debt of 65.16 Million HKD in 2022, up 1732.48% from previous year.
China Biotech Services Holdings Limited reported annual long term debt of 3.55 Million HKD in 2021, down -95.72% from previous year.
China Biotech Services Holdings Limited reported quarterly long term debt of - HKD for 2024 Q2, down 0.0% from previous quarter.
China Biotech Services Holdings Limited reported quarterly long term debt of - HKD for 2023 Q3, down -100.0% from previous quarter.

Annual Long Term Debt Chart of China Biotech Services Holdings Limited (2023 - 2005)

Historical Annual Long Term Debt of China Biotech Services Holdings Limited (2023 - 2005)

Year	Long Term Debt	Long Term Debt Growth
2023	5.72 Million HKD	-91.21%
2022	65.16 Million HKD	1732.48%
2021	3.55 Million HKD	-95.72%
2020	83.07 Million HKD	1265.29%
2019	6.08 Million HKD	279.6%
2018	1.6 Million HKD	-66.32%
2017	4.75 Million HKD	52.53%
2016	3.12 Million HKD	0.0%
2015	- HKD	0.0%
2014	- HKD	0.0%
2013	- HKD	0.0%
2012	- HKD	0.0%
2011	- HKD	0.0%
2010	- HKD	-100.0%
2009	3.06 Million HKD	0.0%
2008	3.06 Million HKD	0.0%
2007	- HKD	0.0%
2006	- HKD	0.0%
2005	- HKD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	- HKD	0.0%
2024 Q2	- HKD	0.0%
2023 Q3	- HKD	-100.0%
2023 Q1	- HKD	-100.0%
2023 FY	5.72 Million HKD	-91.21%
2023 Q2	60.29 Million HKD	0.0%
2023 Q4	5.72 Million HKD	0.0%
2022 Q1	- HKD	-100.0%
2022 FY	65.16 Million HKD	1732.48%
2022 Q4	65.16 Million HKD	0.0%
2022 Q2	50.14 Million HKD	0.0%
2021 Q4	3.55 Million HKD	0.0%
2021 FY	3.55 Million HKD	-95.72%
2021 Q1	- HKD	-100.0%
2021 Q2	4.56 Million HKD	0.0%
2020 Q4	83.07 Million HKD	0.0%
2020 Q2	82.54 Million HKD	0.0%
2020 Q1	- HKD	-100.0%
2020 FY	83.07 Million HKD	1265.29%
2019 Q4	6.08 Million HKD	0.0%
2019 Q2	7.74 Million HKD	0.0%
2019 FY	6.08 Million HKD	279.6%
2019 Q1	- HKD	-100.0%
2018 Q4	1.6 Million HKD	0.0%
2018 Q1	- HKD	-100.0%
2018 Q2	1.58 Million HKD	0.0%
2018 FY	1.6 Million HKD	-66.32%
2017 FY	4.75 Million HKD	52.53%
2017 Q4	4.75 Million HKD	0.0%
2017 Q2	4.7 Million HKD	0.0%
2017 Q1	- HKD	-100.0%
2016 Q2	- HKD	0.0%
2016 Q1	- HKD	0.0%
2016 FY	3.12 Million HKD	0.0%
2016 Q4	3.12 Million HKD	0.0%
2015 Q4	- HKD	0.0%
2015 FY	- HKD	0.0%
2015 Q2	- HKD	0.0%
2015 Q1	- HKD	0.0%
2014 Q2	- HKD	0.0%
2014 Q1	- HKD	0.0%
2014 FY	- HKD	0.0%
2014 Q4	- HKD	0.0%
2013 FY	- HKD	0.0%
2013 Q4	- HKD	0.0%
2013 Q2	- HKD	0.0%
2013 Q3	- HKD	0.0%
2013 Q1	- HKD	0.0%
2012 Q3	- HKD	0.0%
2012 Q1	- HKD	0.0%
2012 FY	- HKD	0.0%
2011 Q3	- HKD	0.0%
2011 FY	- HKD	0.0%
2011 Q1	- HKD	0.0%
2010 Q1	- HKD	0.0%
2010 FY	- HKD	-100.0%
2009 FY	3.06 Million HKD	0.0%
2008 FY	3.06 Million HKD	0.0%
2007 FY	- HKD	0.0%
2006 FY	- HKD	0.0%
2005 FY	- HKD	0.0%

Peer Long Term Debt Comparison of China Biotech Services Holdings Limited

Name	Long Term Debt	Long Term Debt Difference
Life Healthcare Group Limited	2.43 Million HKD	-135.388%